Is Snowflake Stock a Buy Now? The Answer Might Surprise You.

Snowflake reported robust fiscal Q2 2026 results, with product revenue accelerating 32% year-over-year to $1.09 billion and a record $6.9 billion in remaining performance obligations, driving a 20% surge in its stock. The company is expanding its AI product portfolio, including Cortex AI, leveraging its Data Cloud to facilitate enterprise AI development for a growing customer base. However, despite operational strength, Snowflake continues to incur significant GAAP net losses, and its elevated valuation at 20.8x price-to-sales may limit near-term upside.

Analysis

Snowflake's fiscal second-quarter 2026 results reveal a significant operational inflection point, marked by an acceleration in product revenue growth to 32% year-over-year, reaching $1.09 billion and reversing a multi-year trend of deceleration. This performance, which beat management's $1.04 billion guidance, is underpinned by a record $6.9 billion in Remaining Performance Obligations (RPOs), up 33% YoY, and a rising net revenue retention rate of 125%. These metrics indicate strong future demand and successful monetization of new AI-centric products like Cortex AI, with over 6,100 of its 12,062 customers now using these tools weekly. However, this top-line strength is sharply contrasted by significant profitability issues. The company posted a GAAP net loss of $298 million for the quarter, contributing to a record first-half loss of $728 million. A substantial portion of this loss is attributable to $436 million in stock-based compensation, a non-cash expense that nonetheless dilutes shareholder value. The primary headwind for investors is valuation; trading at a one-year high price-to-sales ratio of 20.8, the stock is priced at a significant premium to cloud peers, potentially capping near-term upside despite the robust business momentum.

Key Decisions for Investors

• Given the accelerating revenue and strong AI product adoption, long-term growth investors may find the operational momentum compelling, but must tolerate high valuation and sustained GAAP losses.
• Investors should scrutinize the company's elevated price-to-sales ratio of 20.8 and the significant dilutive impact of stock-based compensation, which may justify waiting for a more favorable entry point after the recent 20% stock surge.
• Closely monitor growth in Remaining Performance Obligations (RPOs) and the net revenue retention rate in subsequent quarters, as continued strength in these areas is critical to justifying the stock's premium valuation.